Skip to main content
Equibles

Cormorant Asset Management, LP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1583977 BOSTON, MA
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,588,500
-$6,013,500 QoQ
Shares Held
175,000
-61.1% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#77
of 271 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. ARQT ranks #38 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 640,000 $214,265,600
2 BBOT
BridgeBio Oncology Therapeutics, Inc.
 17,878,594 $136,234,886
3 PBLS
Parabilis Medicines, Inc.
 4,615,612 $126,329,300
4 RAPP
Rapport Therapeutics, Inc.
 2,657,521 $110,738,900
5 ERAS
Erasca, Inc.
 6,000,000 $109,920,000
6 EWTX
Edgewise Therapeutics, Inc.
 2,510,000 $101,981,300
7 EYPT
EyePoint, Inc.
 7,000,000 $100,100,000
8 ALMS
Alumis Inc.
 3,285,596 $92,456,671

All Filings in ARQT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,588,500 175,000
2026-03-31 $10,602,000 450,000
2025-12-31 $14,520,000 500,000
2025-09-30 $14,608,750 775,000
2025-06-30 $14,020,000 1,000,000
2025-03-31 $21,114,000 1,350,000
2024-12-31 $25,422,250 1,825,000
2024-09-30 $21,622,500 2,325,000
2024-06-30 $23,482,500 2,525,000
2024-03-31 $21,058,750 2,125,000
2023-06-30 $7,624,000 800,000
2022-12-31 $9,620,000 650,000
2022-09-30 $19,110,000 1,000,000